Abstract:Objective To investigate the pharmacokinetics of gemifloxacin in healthy Chinese subjects in order to provide rationale for developing safe and effective clinical dosage regimen in Chinese patients.Methods Twelve subjects were enrolled in an open label,3-period,single oral dose,cross-over pharmacokinetic study. The subjects sequentially took 3 doses of gemifloxacin (160 mg,320 mg and 480 mg) according to the randomization schedule. The concentrations of gemifloxacin in serum and urine were determined by high performance liquid chromatogram (HPLC). The pharmacokinetic parameters were analyzed by Winnonlin software.Results The pharmacokinetic courses following single crossover oral dose of 160 mg,320 mg and 480 mg gemifloxacin were all consistent with the non-compartment model. The means of C max were (0.70±0.19) mg/L,(1.40±0.32) mg/L and (1.84±0.35) mg/L,respectively. The medians of T max were 1 (0.5,2) h,1 (0.5,2) h and 1.25 (1,2) h,respectively. The means of t 1/2 were (7.06±1.22) h,(7.02±0.94) h and (7.28±0.81) h,respectively. The means of AUC 0-24 h were (3.86±0.56) mg·h/L,(7.61±0.93) mg·h/L and (11.47±1.68) mg·h/L,respectively. The means of AUC 0-∞ were (4.01±0.57) mg·h/L,(7.71±0.92) mg·h/L and (11.62±1.72) mg·h/L,respectively. The means of V d were (411.45±77.88) L,(423.47±59.48) L and (439.21±55.55) L,respectively. The means of CL t were (40.71±6.22) L/h,(42.10±5.46) L/h and (42.26±7.14) L/h,respectively. The means of accumulative urinary excretion at 48 hours post dosing were (38.95±6.14)%,(37.84±6.62)% and (35.57±5.07)%,respectively. Conclusions The results indicate that pharmacokinetic courses following single oral dose of 160 mg,320 mg and 480 mg gemifloxacin are linear. The half-life is long. Gemifloxacin is partly excreted from kidney. About 40% of the dosage is recovered in the urine at 48 hours post dosing.

Study of the Pharmacokinetics and Bioequivalence of Gatifloxacin Dispersible Tablets in Chinese Healthy Volunteers

A Study of the Bioequivalence of Fleroxacin Tablets in Healthy Chinese Volunteers

Bioequivalence of Levofloxacin Hydrochloride Tablets in Chinese Healthy Volunteers

Pharmacokinetic and Bioequivalence Evaluation of Two Cefprozil Dispersible Tablets in Healthy Chinese Volunteers

Study of the Bioequivalence of Gliclazide in Chinese Healthy Volunteers

Study on Pharmacokinetics of Multi-Dose of Oral Gatifloxacin Methanesulfonate Tablets in Healthy Volunteers

Pharmacokinetics of Gatifloxacin Tablet in Healthy Volunteers

Study On Bioequivalence Of Voriconazole Dispersible Tablets In Healthy Volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

A study on multi-dose pharmacokinetics of gatifloxacin mesylate in healthy volunteers

Relative bioavailability of cefpodoxime proxetil tablets in healthy volunteers

The bioavailability of ofloxacin tablets in healthy volunteers

Bioequivalence of glipizide orally disintegrating tablets in healthy volunteers

Pharmacokinetics of gatifloxacin mesylate tablet in healthy volunteers after a single oral administration

Pharmacokinetics and Bioequivalence Study of Cefixime Tablet in Healthy Volunteers

Pharmacokinetic and bioequivalence studies of ibuprofen suspension after a single-dose administration in healthy Chinese volunteers.

Clinical pharmacokinetics of gemifloxacin following single oral dose administration in healthy Chinese male subjects

Pharmacokinetics and Bioequivalence of 2 Kinds of Amoxicillin Dispersible Tablets in Healthy Volunteers

Pharmacokinetics and Bioequivalence of Citric Acid Tamoxifen Dispersible Tablet in Healthy Volunteers

Relative bioavailability and bioequivalence of ibuprofen orally disintegrating tablets in healthy volunteers